NHTCNasdaqWholesale-Miscellaneous Nondurable GoodsFiscal year ends December 31

NATURAL HEALTH TRENDS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$0.94−0.03 (-3.06%)

Close on Oct 19, 2026

Market cap: $8.07M
P/E (TTM): –
Dividend yield: 85.08%

NATURAL HEALTH TRENDS CORP income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	40	43	44	49	60	62	78	192	198	288	265	125	53	38	31	24
Cost of Revenue	11	11	11	13	15	17	20	39	39	55	54	27	13	9.69	8.17	6.97
Gross Profit	29	32	33	36	45	45	58	153	159	233	211	98	40	28	23	17
Selling, General & Admin	15	16	16	16	18	18	27	31	32	43	36	20	12	9.42	9.05	9.80
Operating Expenses	31	33	34	37	43	44	65	119	116	169	163	77	36	25	21	20
Operating Income	-1.81	-1.30	-1.67	-0.27	1.57	0.67	-7.02	34	43	64	48	21	4.22	2.65	1.78	-3.08
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.02	0.02
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.01	0.01
Other Non-Operating Income	1.24	1.92	2.42	0.87	-0.06	0.82	1.43	0.79	0.37	-0.06	-0.08	-0.18	-0.03	-0.04	0.34	0.58
Asset Impairment Charges	–	–	–	–	–	0	1.76	0	–	–	0	0	0	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.05	0.06
Pretax Income	-0.57	0.62	0.75	0.60	1.51	1.49	-5.60	35	43	64	48	21	4.19	2.61	–	–
Income Tax Expense	0.32	0.05	0.18	0.29	0.43	0.65	0.01	3.49	20	8.99	0.55	0.27	0.10	-0.02	-0.30	-0.03
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	4.09	2.63	2.43	-2.47
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.12	-0.02
Net Income	-0.88	0.57	0.57	0.31	1.09	0.84	-5.61	31	24	55	47	20	4.09	2.63	2.31	-2.45
Preferred Dividends	–	–	–	–	–	–	–	–	–	0	0	0.01	0.02	0.02	0.02	-0.02
Net Income to Common	-0.88	0.57	0.57	0.31	1.09	0.84	-5.61	31	24	55	47	20	4.07	2.61	2.29	-2.46
EPS (Basic)(per share)	-0.08	0.05	0.05	0.03	0.10	0.08	-0.52	2.75	2.10	4.84	3.84	1.67	0.36	–	0.21	-0.23
EPS (Diluted)(per share)	-0.08	0.05	0.05	0.03	0.09	0.07	-0.52	2.74	2.09	4.83	3.82	1.61	0.36	0.23	0.21	-0.23
Shares Outstanding (Basic, Weighted)(shares)	11	11	11	11	11	11	11	11	11	11	12	12	11	11	11	11
Shares Outstanding (Diluted, Weighted)(shares)	11	11	11	11	11	11	11	11	11	11	12	13	11	11	11	11
Dividend per Share(per share)	0.80	0.80	0.80	0.80	0.80	0.80	0.64	2.77	1.52	0.61	0.14	0.03	–	–	–	–
EBITDA	-1.70	-1.17	-1.51	-0.07	1.87	1.08	-6.64	–	44	65	48	21	4.29	2.69	2.08	-1.87

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 74.1%
Operating margin: -6.2%
Net margin: -4.5%
Return on equity, FY2025: -3.1%

Financial strength

Current ratio: 1.99
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 79.6%

Valuation

P/E ratio: –
Price to sales: 0.22
Price to book: 0.53
Dividend yield: 85.08%